APA (7th ed.) Citation

Hasni, S., Temesgen-Oyelakin, Y., Davis, M., Chu, J., Poncio, E., Naqi, M., . . . Kaplan, M. J. (2022). Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus. Annals of the rheumatic diseases, 81(11), 1576-1584. https://doi.org/10.1136/ard-2022-222658

Chicago Style (17th ed.) Citation

Hasni, Sarfaraz, et al. "Peroxisome Proliferator Activated Receptor-γ Agonist Pioglitazone Improves Vascular and Metabolic Dysfunction in Systemic Lupus Erythematosus." Annals of the Rheumatic Diseases 81, no. 11 (2022): 1576-1584. https://doi.org/10.1136/ard-2022-222658.

MLA (9th ed.) Citation

Hasni, Sarfaraz, et al. "Peroxisome Proliferator Activated Receptor-γ Agonist Pioglitazone Improves Vascular and Metabolic Dysfunction in Systemic Lupus Erythematosus." Annals of the Rheumatic Diseases, vol. 81, no. 11, 2022, pp. 1576-1584, https://doi.org/10.1136/ard-2022-222658.